The median waiting time for Percutaneous Transluminal Coronary Angioplasty (PTCA) in the UK shows a stable forecast, increasing slightly to 43 days from the 2023 baseline of 42 days. From 2024 to 2028, waiting times remain constant at 43 days post the slight 2.38% rise noted in 2025. The compound annual growth rate (CAGR) over this period is minimal, illustrating a stable system of healthcare delivery with controlled demand relative to supply capacity.
Future trends to watch include advancements in scheduling technologies or policies aimed at reducing waiting times further, alongside demographic changes that may impact the demand for PTCA procedures.
Our readers also like:
Forecast: Pacemakers and Hearing Aids Market Size Value in Spain
- Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in the UK
- Percent of Patients Waiting 3 Months +
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in the UK
- Days, Median
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiovascular System Medicine Sales in Spain
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in the UK
- Days, Mean
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Germany
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in Italy
- Percent of Patients Waiting 3 Months +
- 2024 to 2028
- ReportLinker Research
Forecast: Ischaemic Heart Diseases Mortality in Spain
- Units (Male Deaths)
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Spain
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Spain
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in Italy
- Days, Mean
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiac Glycosides Sales in Belgium
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Belgium
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in Italy
- Days, Median
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiac Glycosides Sales in Spain
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Germany
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in the UK
- Percent of Patients Waiting 3 Months +
- 2024 to 2028
- ReportLinker Research
Forecast: Waiting Time for Percutaneous Transluminal Coronary Angioplasty Performed in the UK
- Days, Mean
- 2024 to 2028
- ReportLinker Research
Pacemakers and Hearing Aids Market Size Value in Spain
- Euros
- 2010 to 2023
- ReportLinker Research
Forecast: Cardiovascular System Medicine Use in Spain
- Units (Defined Daily Dosage) Per Thousand Persons Per Day
- 2024 to 2028
- ReportLinker Research